Flucke UE - Search Results

1

Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models.

Fleuren ED, Versleijen-Jonkers YM, Roeffen MH, Franssen GM, Flucke UE, Houghton PJ, Oyen WJ, Boerman OC, van der Graaf WT. Fleuren ED, et al. Among authors: flucke ue. Int J Cancer. 2014 Dec 15;135(12):2770-82. doi: 10.1002/ijc.28933. Epub 2014 May 5. Int J Cancer. 2014. PMID: 24771207 Free article.

2

The diagnostic hurdle of an elderly male with bone pain: how 18F-FDG-PET led to diagnosis of a leiomyosarcoma of the adrenal gland.

Van Laarhoven HW, Vinken M, Mus R, Flucke U, Oyen WJ, Van der Graaf WT. Van Laarhoven HW, et al. Anticancer Res. 2009 Feb;29(2):469-72. Anticancer Res. 2009. PMID: 19331188 Free article.

3

Malignant transformation in an area with elevated F-18 FDG uptake within a low metabolic benign neurofibroma.

van de Luijtgaarden AC, Flucke UE, van der Graaf WT, de Rooy JW, Bonenkamp HJ, de Geus-Oei LF. van de Luijtgaarden AC, et al. Among authors: flucke ue. Clin Nucl Med. 2010 Apr;35(4):271-2. doi: 10.1097/RLU.0b013e3181d18ff1. Clin Nucl Med. 2010. PMID: 20305421 No abstract available.

4

Imaging of HIV-associated Kaposi sarcoma; F-18-FDG-PET/CT and In-111-bevacizumabscintigraphy.

van de Luijtgaarden A, van der Ven A, Leenders W, Kaal S, Flucke U, Oyen W, van der Graaf W. van de Luijtgaarden A, et al. J Acquir Immune Defic Syndr. 2010 Aug;54(4):444-6. doi: 10.1097/QAI.0b013e3181cdf61f. J Acquir Immune Defic Syndr. 2010. PMID: 20611036 No abstract available.

5

Benign uterine uptake of FDG: a case report and review of literature.

Vriens D, de Geus-Oei LF, Flucke UE, van der Kogel AJ, Oyen WJ, Vierhout ME, van der Meer JW. Vriens D, et al. Among authors: flucke ue. Neth J Med. 2010 Sep;68(9):379-80. Neth J Med. 2010. PMID: 20876921 Free article. Review. No abstract available.

6

Age as prognostic factor in patients with osteosarcoma.

Hagleitner MM, Hoogerbrugge PM, van der Graaf WT, Flucke U, Schreuder HW, te Loo DM. Hagleitner MM, et al. Bone. 2011 Dec;49(6):1173-7. doi: 10.1016/j.bone.2011.08.014. Epub 2011 Aug 26. Bone. 2011. PMID: 21893224

7

Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.

van Gaal JC, Flucke UE, Roeffen MH, de Bont ES, Sleijfer S, Mavinkurve-Groothuis AM, Suurmeijer AJ, van der Graaf WT, Versleijen-Jonkers YM. van Gaal JC, et al. Among authors: flucke ue. J Clin Oncol. 2012 Jan 20;30(3):308-15. doi: 10.1200/JCO.2011.37.8588. Epub 2011 Dec 19. J Clin Oncol. 2012. PMID: 22184391

8

The impact of age on outcome of embryonal and alveolar rhabdomyosarcoma patients. A multicenter study.

Van Gaal JC, Van Der Graaf WT, Rikhof B, Van Hoesel QG, Teerenstra S, Suurmeijer AJ, Flucke UE, Loeffen JL, Sleijfer S, De Bont ES. Van Gaal JC, et al. Among authors: flucke ue. Anticancer Res. 2012 Oct;32(10):4485-97. Anticancer Res. 2012. PMID: 23060577

9

Prognostic and therapeutic relevance of the IGF pathway in Ewing's sarcoma patients.

van de Luijtgaarden AC, Versleijen-Jonkers YM, Roeffen MH, Schreuder HW, Flucke UE, van der Graaf WT. van de Luijtgaarden AC, et al. Among authors: flucke ue. Target Oncol. 2013 Dec;8(4):253-60. doi: 10.1007/s11523-012-0248-3. Epub 2013 Jan 6. Target Oncol. 2013. PMID: 23292309

10

Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I.

Vlenterie M, Flucke U, Hofbauer LC, Timmers HJ, Gastmeier J, Aust DE, van der Graaf WT, Wesseling P, Eisenhofer G, Lenders JW. Vlenterie M, et al. Am J Med. 2013 Feb;126(2):174-80. doi: 10.1016/j.amjmed.2012.07.022. Am J Med. 2013. PMID: 23331445 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page